Dalbavancin Market Size, Share, Analysis Report

Dalbavancin Market Size By Type (Intravenous Therapy, Oral Type), By Application (Skin Infection, Soft Tissue Infection), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast

The global Dalbavancin market report scope includes detailed study covering underlying factors influencing the industry trends.

Purchase User License

MARKET SNAPSHOT

Major Players

  • Sanofi
  • Merck
  • Novartis
  • Gilead
  • GSK
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    19

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Dalbavancin is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA).

    Growth in the market can be attributed to increase in Complicated skin and soft-tissue infection.

    The global Dalbavancin market is segregated on the basis of Type as Intravenous Therapy and Oral Type. Based on Application the global Dalbavancin market is segmented in Skin Infection, Soft Tissue Infection, and Others.

    The global Dalbavancin market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Dalbavancin market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

    Competitive Rivalry

    Sanofi, Merck, Novartis, Gilead, GSK, Amgen, Hayao, Pfizer, Abbvie, Johnson, and others are among the major players in the global Dalbavancin market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Dalbavancin Market has been segmented as below:

    Dalbavancin Market, By Type

    • Intravenous Therapy
    • Oral Type

    Dalbavancin Market, By Application

    • Skin Infection
    • Soft Tissue Infection
    • Others

    Dalbavancin Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Dalbavancin Market, By Company

    • Sanofi
    • Merck
    • Novartis
    • Gilead
    • GSK
    • Amgen
    • Hayao
    • Pfizer
    • Abbvie
    • Johnson

    The report covers:

    • Global Dalbavancin market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global Dalbavancin market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Dalbavancin market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report Scope:

    The global Dalbavancin market report scope includes detailed study covering underlying factors influencing the industry trends.

    The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

    The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Dalbavancin market share. Major industry players with significant revenue share include Sanofi, Merck, Novartis, Gilead, GSK, Amgen, Hayao, Pfizer, Abbvie, Johnson, and others.

    Reasons to Buy this Report:

    • Gain detailed insights on the Dalbavancin industry trends
    • Find complete analysis on the market status
    • Identify the Dalbavancin market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Customization

    Customized report as per the requirement can be offered with appropriate recommendations.

    Below are our New Reports :-

    Sexually Transmitted Disease Therapeutics Market

    Robotic Pharmacy Prescription Dispensing Systems Market

    Laboratory Information Management System Market

    Immunofluorescence Analyzers market

    High-performance Liquid Chromatography (HPLC) Market

    1. Introduction
        1.1 Key Insights
        1.2 Report Overview
        1.3 Markets Covered
        1.4 Stakeholders

    2. Research Methodology
        2.1 Research Scope
        2.2 Market Research Process
        2.3 Research Data Analysis
            2.4.1 Secondary Research
            2.4.2 Primary Research
            2.4.3 Models for Estimation
        2.5 Market Size Estimation
            2.5.1 Bottom-Up Approach – Segmental Market Analysis
            2.5.2 Top-Down Approach – Parent Market Analysis

    3. Executive Summary

    4. Market Overview
        4.1 Introduction
            4.2.1 Drivers
            4.2.2 Restraints
            4.2.3 Opportunities
            4.2.4 Challenges
        4.2 Porter’s Five Force Analysis

    5. Dalbavancin Market, By Type
        5.1 Introduction
        5.2 Intravenous Therapy
            5.2.1 Market Overview
            5.2.2 Market Size and Forecast
        5.3 Oral Type
            5.3.1 Market Overview
            5.3.2 Market Size and Forecast

    6. Dalbavancin Market, By Application
        6.1 Introduction
        6.2 Skin Infection
            6.2.1 Market Overview
            6.2.2 Market Size and Forecast
        6.3 Soft Tissue Infection
            6.3.1 Market Overview
            6.3.2 Market Size and Forecast
        6.4 Others
            6.4.1 Market Overview
            6.4.2 Market Size and Forecast

    7. Dalbavancin Market, By Geography
        7.1 Introduction
        7.2 North America
            7.2.1 North America Dalbavancin, By Type
            7.2.2 North America Dalbavancin, By Application
        7.3 Europe
            7.3.1 Europe Dalbavancin, By Type
            7.3.2 Europe Dalbavancin, By Application
        7.4 Asia-Pacific
            7.4.1 Asia-Pacific Dalbavancin, By Type
            7.4.2 Asia-Pacific Dalbavancin, By Application
        7.5 Rest of the World
            7.5.1 Rest of the World Dalbavancin, By Type
            7.5.2 Rest of the World Dalbavancin, By Application

    8. Competitive Insights
        8.1 Key Insights
        8.2 Company Market Share Analysis
        8.3 Strategic Outlook
            8.3.1 Mergers & Acquisitions
            8.3.2 New Product Development
            8.3.3 Portfolio/Production Capacity Expansions
            8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
            8.3.5 Others

    9. Company Profiles
        9.1 Sanofi
            9.1.1 Company Overview
            9.1.2 Product/Service Landscape
            9.1.3 Financial Overview
            9.1.4 Recent Developments
        9.2 Merck
            9.2.1 Company Overview
            9.2.2 Product/Service Landscape
            9.2.3 Financial Overview
            9.2.4 Recent Developments
        9.3 Novartis
            9.3.1 Company Overview
            9.3.2 Product/Service Landscape
            9.3.3 Financial Overview
            9.3.4 Recent Developments
        9.4 Gilead
            9.4.1 Company Overview
            9.4.2 Product/Service Landscape
            9.4.3 Financial Overview
            9.4.4 Recent Developments
        9.5 GSK
            9.5.1 Company Overview
            9.5.2 Product/Service Landscape
            9.5.3 Financial Overview
            9.5.4 Recent Developments
        9.6 Amgen
            9.6.1 Company Overview
            9.6.2 Product/Service Landscape
            9.6.3 Financial Overview
            9.6.4 Recent Developments
        9.7 Hayao
            9.7.1 Company Overview
            9.7.2 Product/Service Landscape
            9.7.3 Financial Overview
            9.7.4 Recent Developments
        9.8 Pfizer
            9.8.1 Company Overview
            9.8.2 Product/Service Landscape
            9.8.3 Financial Overview
            9.8.4 Recent Developments
        9.9 Abbvie
            9.9.1 Company Overview
            9.9.2 Product/Service Landscape
            9.9.3 Financial Overview
            9.9.4 Recent Developments
        9.10 Johnson
            9.10.1 Company Overview
            9.10.2 Product/Service Landscape
            9.10.3 Financial Overview
            9.10.4 Recent Developments

    The Dalbavancin Market has been segmented as below:

    Dalbavancin Market, By Type

    • Intravenous Therapy
    • Oral Type

    Dalbavancin Market, By Application

    • Skin Infection
    • Soft Tissue Infection
    • Others

    Dalbavancin Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Dalbavancin Market, By Company

    • Sanofi
    • Merck
    • Novartis
    • Gilead
    • GSK
    • Amgen
    • Hayao
    • Pfizer
    • Abbvie
    • Johnson

    Got a question? We've got answers. If you have some other questions, see our support center.

    The segment included in the Dalbavancin Market is Type, Application and region.
    Some key players operating in the Dalbavancin Market include Sanofi, Merck, Novartis, Gilead, GSK, Amgen, Hayao, Pfizer, Abbvie, Johnson
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports